Anesthesia Video Laryngoscope Market – New Market Research Report Announced; Global Industry Analysis 2016 – 2024
Video laryngoscope device is used to view anatomical structure of the larynx for detailed examination.
The visualization of the larynx is done with a digital laryngoscope or fiber optic inserted transorally or transnasally. The images are recorded for a more detailed examination. Larynx examination can be performed by indirect laryngoscopy and direct laryngoscopy. Direct laryngoscopy includes setting of tube (laryngoscope) in the back of the throat which helps the specialist to inspect the throat and eliminate the contaminated tissue for biopsy. The process of tissue removal (biopsy) is normally done after the administration of anesthesia. Indirect laryngoscopy predominantly includes visualization of upper tracheal rings, vocal cords, and larynx. Growing awareness among healthcare professionals about technologically advanced video laryngoscopes and its advantages over traditional laryngoscopes are helping in expanded use beyond hospital settings which are the factors impelling the growth of the global anesthesia video laryngoscope market. Recently, several companies have started developing video laryngoscope products which are self-contained, lightweight, wireless, and battery operated as they are easy to operate. Increasing use during robot-assisted intubation is a trending factor which is expected to spur the global anesthesia video laryngoscope market growth through 2024. Also, the adoption of advanced products such as portable anesthesia video laryngoscopes is high owing to similar functions and configurations such as conventional curved and angulated laryngoscope without the extra difficulty of training that increases physician’s preference for anesthesia video laryngoscope devices. However, some challenges faced during the use of anesthesia video laryngoscopes are voice pitch complications, breathing problems, internal bleeding, and irritation. Also, high cost of devices and availability of alternative devices are certain challenges which may hamper the global anesthesia video laryngoscope market growth.
The global anesthesia video laryngoscope market has been segmented by type of laryngoscopy, by end user and by geography. In terms of laryngoscopy type, anesthesia video laryngoscope has been categorized into rigid laryngoscope and transnasal flexible laryngoscope. Furthermore, rigid laryngoscope will dominate the video laryngoscope market in terms of value in 2015. The rising awareness regarding minimally invasive surgery along with the use of video laryngoscopes compels the growth of the market. Based on end user segmentation, the anesthesia video laryngoscope has been categorized into diagnostic laboratories, hospitals, and ENT clinics. Among the end user type of anesthesia laryngoscope, hospitals are expected to contribute maximum share as compared to diagnostic laboratories and ENT clinics.
Depending on geographic segmentation, the global anesthesia video laryngoscopes market is segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to contribute significant share in the global market for anesthesia video laryngoscope owing to extensive awareness of advanced products and research & development activities in the region. Presence of well-established healthcare organization, promising government initiatives in implementing anesthesia video laryngoscope in the surgeries and constantly improving reimbursement scenario expected to propel the market growth during the forecast period. Europe was second largest contributor in the anesthesia video laryngoscope market due to enhanced healthcare processes and increased implementation of minimally invasive surgeries in the region. Asia Pacific and Latin America are expected to gain market share at rapid pace in the forecast period. The major factors which are expected drive the market growth in Asia Pacific include the improving healthcare infrastructure and the increasing awareness levels for surgery treatment options. Latin American countries such as Brazil and Mexico are expected to have considerable potential for driving the market growth due to high disposable income and evolving medical structure. The major players operating in this market include Ambu A/S, Medtronic plc, Clarus Medical LLC, BOMIMED, Teleflex Incorporated, Verathon Inc., KARL STORZ GmbH & Co. KG, Venner Medical (Deutschland) GmbH, and XION GmbH among other significant players worldwide.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16511
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Expression proteomics includes the study of the dysregulated proteins as a function of stimulation or patient condition. The patient condition depends on the disease or specific drugs related to any disease. The market for expression proteomics is segmented into four major categories, on the basis of applications, by expression system, by products and by the End users. By expression system, market of expression proteomics consists of four segments including:
Among the expression system segments, the major market share is commanded by prokaryotic segment. The use of Escherichia Coli (E.Coli) is mostly preferred as a host cell due to its easy availability and cheap protein expression and production. Mammalian segment is also showing increased growth as demand for therapeutic proteins has increased leading to need for proteins with post-translational modification and increasing use of mammalian expression systems.
The market for expression proteomics on the basis of the product is differentiated into four major segments which include:
- Competent Cells
- Expression vectors
In the product segment for expression proteomics market, reagents is the major revenue generating product driven by the demand of immunoassays, microarray reagents and spectroscopy reagents. These reagents are easy to use and are less expensive comparatively and therefore, used in large number for transfection and maintenance of cell lines. Instruments are further divided into six major categories according to the techniques involved in expression proteomics namely microarrays, mass spectrometers, NMR spectrometers, chromatography, electrophoresis, surface plasmon resonance and X-ray crystallography. Among these protein microarrays are dominating the market followed by spectroscopy technique.
On the basis of application of expression proteomics, the market is divided into three segments including:
- Industrial proteins
- Research applications
- Therapeutic proteins
Among these segments, therapeutic proteins are dominating the market for expression proteomics due to its versatile advantage over other small molecule drugs to alleviate diseases. On the basis of end users, the market is majorly classified into three parts namely pharmaceutical, biotechnology and research organizations.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2440
The market for expression proteomics is growing at faster pace majorly driven by the globally increasing intensity in research in the pharmaceutical and biological sector. Additionally, the factors such as increased demand for personalized medicine, technological advancement and increasing use of proteomic outcomes in diagnosis and drug discovery also propels the market growth. However, reduction in funding towards sequestration cuts in U.S., high cost of expression proteomics tools, difficulty in gaining regulatory approvals and dearth of qualified researchers are some of the factors which are restraining the growth of this market to some extent.
North America currently leads the global market for expression proteomics followed by Europe. The major factors driving the expression proteomics market in these regions are the technological advancements and rising demand for the expression proteomics in personalized medicines. The expression proteomics market in Asia-Pacific is also showing rapid growth due to increasing government and private funding towards research and development in countries such as Japan, India, Australia and China. The major key players in the expression proteomics market include ActivX Biosciences, Inc, Agilent Technologies, Inc., Life Technologies Corporation, New England Biolabs, Inc., QIAGEN, Takara Bio, Inc., Bio-Rad Laboratories, Merck Millipore, Hybrigenics SA , Tyrian Diagnostics, Ltd, Luminex Corporation, Promega Corporation, Danaher Corporation , Caprion Proteomics, Inc Sigma-Aldrich Corporation and Thermo Fischer Scientific, Inc.
An individual’s genetic makeup is determined by DNA sequences comprising varied combinations of nucleotides namely, adenine, thymine, cytosine, and guanine. Alterations of the genetic code and consequent undesirable traits or disease conditions can occur due to variation in these DNA sequences. Genotyping helps determine differences in the individual’s genetic makeup wherein the individuals DNA sequence is examined using biological assays and is compared to another individuals DNA sequence or a reference sequence. Genotyping analysis plays an important role in research of genes and gene variants associated with disease. Single nucleotide polymorphisms (SNPs) are the most common form of variation which occurs on change in single nucleotide in the genome sequence. SNP genotyping is rapidly growing as a useful tool in many scientific disciplines including personalized medicine, plant and animal biotechnology.
The various methods used for genotyping analysis include polymerase chain reaction (PCR), amplified fragment length polymorphism detection (AFLPD), random amplified polymorphic detection (RAPD) of genomic DNA, allele specific oligonucleotide (ASO) probes, DNA sequencing, restriction fragment length polymorphism identification (RFLPI) of genomic DNA, and hybridization to DNA microarrays or beads. Genotyping can be applied to humans as well as microorganisms. Genotyping of viruses or bacteria may help in tracing the origin of outbreak and thus control the spread of pathogens. Genotyping develops and provides innovative technologies that enable multiplex and parallel analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of results into biology for a better world. Genotyping researchers face major challenge in studying rare variants most effectively. Whole-genome sequencing is preferred by some for studying rare variants, however often it is too slow and too expensive while microarrays are more cost-effective and allow for higher-throughput.
The global genotyping analysis services market is segmented based on various services provided by the key players. These companies provide diverse portfolio of genotyping analysis service offerings such as human whole genome sequencing services, microarray services, long read sequencing services, certified service provider program and other services such as core lab program, service partnerships, analysis and data management solutions as custom array service, whole genome services and genome-wide genotyping services. Growing demand from pharmacogenomics, diagnostic research and animal breeding are some of the factors driving the market growth. Developing as well as developed countries are expected to witness increasing demand for genotyping services that are within the reach of a common man, since people want to understand their genetic make-up in terms of aesthetic awareness in terms of height, weight, obesity or for diseases such as diabetes, cancer, cardiovascular and others.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2441
Rising interest in personalized genomic analysis and growing thrust for using rapidly increasing knowledge regarding individual genetic variations to personalize diagnosis as well as treatment is also responsible for driving the growth of the market. However, this direct to consumer model for providing genetic analysis directly to an individual has been posing a problem due to concerns from FDA regulatory agencies about providing health care information directly to non-professionals. Healthcare providers may make it a general practice for routine DNA sequencing on patients thus making it needless for individuals to initiate it themselves.
On the other hand, technological limitation has been a major constrain to the growth of global genotyping analysis services market which leads to determination of only small fraction of an individual’s genotype. Moreover, issues involving intellectual property and ethics will need to be addressed before personalized medicine can become a true reality.
Some of the key service providers in global genotyping analysis market include Affymetrix, Illumina, Harlan Laboratories, Fluidigm, Life Technologies, Sequenome and Roche Diagnostics.
U.S. Bioremediation Technologies and Services Market Analysis, Growth, Trends and Forecast up to 2019
Bioremediation is a scientific waste management process that uses various, fungi, microorganisms, green plants and their enzymes to reinstate the environment to its original state after removing pollutants from a contaminated site. Bioremediation of water and soil, which is polluted by oil and other industrial waste; is performed by a variety of microorganisms that survive on hydrocarbons. Degradation of pollutants by bacterial microorganisms breaks down the hazardous substances into less toxic biodegradable substances. However, not all pollutants and contaminants are treated by bioremediation using microorganisms. For example, metals such as lead and cadmium are not easily captured or absorbed by microorganisms.
The overall bioremediation technologies and services market is expected to witness an admirable growth due to the increasing awareness for environmental safety and protection. Moreover, stringent government regulations and policies for environmental restoration initiatives is further fuelling the popularity of biotechnology based bioremediation technologies and services globally. Furthermore, novel bioremediation technologies such as bioaugmentation and biostimulation are gaining wide acceptance and interest due to their enhanced environmental restoration capabilities. These technologies use nutrient additives and external microbial agents for remediation of huge amounts of hydrocarbon-contaminated liquids and soil. Additionally, potential technological breakthroughs will generate abundant opportunities for bioremediation technologies and services.
Some of the bioremediation technologies usually used for reinstating and de-contamination the environment are as follows:
- Air Sparging
- Fungal Remediation
Various bioremediation services used for restoring our environment are as follows:
- Sample collection and analysis
- Manufacture of site-specific bioremediation products
- Design of optimized bioremediation program
- Characterization and spill evaluation of environmental parameters
- Report results
- Field services
In the geographical analysis, North America closely followed by Europe is the largest market for bioremediation technologies and services owing to the stringent environmental protection policies and regulations as well as oil spill accidents. For instance, a recent oil spill accident happened in the city of Los Angeles witnessed an oil spill of nearly 50,000 gallons which had ultimately contaminated the soil. These industrial hazards, which occur frequently across the globe, are expected to propel the sales of bioremediation technologies and services in these regions. Moreover, strict orders and policies from environmental protection agencies and groups are also compelling various industrial units to treat their waste products before releasing it in the environment. However, other regions such as South East Asia, Latin America and Middle East are expected to be the potential markets in the near future. Due to the increase in industrial plants and stringent environment safety concerns, these regions are expected to be the potential markets in the near future .
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2468
Other factors such as frequent oil spills in oceans from oil tankers are compelling oil and gas companies to adopt bioremediation technologies as well as services to restore the environment to its original state. However, high development cost and low adoption rate among population are some of the market-restraining factors that might hinder the growth of the overall bioremediation technologies and services market.
At present, the bioremediation technologies and services market is highly fragmented owing to the involvement of many established and emerging players in this industry. However, the key players involved with the development of bioremediation technologies and services are ABB Environmental Services, Inc., Altogen Labs, Bioremediation Service, Inc., Dow Chemical Company, EG&G, Inc., E. I. du Pont de Nemours and Company, Envirogen Technologies, General Electric and Sevenson Environmental Services, Inc.
The soaring demand for antibiotics, on account of the alarming rise in the prevalence of various infections and food-borne diseases, has provided a significant thrust to microbiology culture practices across the world over the last few years. According to the Centers for Disease Control and Prevention (CDC), in the U.S. alone, a total of 23.6 million cases of infectious and parasitic diseases were reported in 2010. Since microbiology culture is an efficient diagnosis method to detect the cause of a number of infectious diseases, its application in the production of antibiotic drugs is witnessing a remarkable rise, worldwide.
The consumption of antibiotics is also experiencing a sturdy growth in the BRICS nation. A 2014 report by Lancet Infectious Diseases Commission stated that the consumption of antibiotic drugs increased globally by 36% from 2000 to 2010, wherein BRICS countries accounted for a share of 76% of this growth. All these factors, together, point towards an opportunity-rich future for the worldwide market for microbiology culture over the coming years.
The global market is projected to witness an increase in its opportunity from US$4.5 bn in 2014 to US$7.5 bn in 2023, expanding at a CAGR of 5.90% during the period from 2015 to 2023. The advent of food microbiology, the rise in concerns over food safety, and the increase in the government funding in life science research are some of the other factors expected to drive the global microbiology culture market in the near future.
North America to Retain Dominance in Terms of Revenue
On the basis of region, the global microbiology culture market is segmented into Asia Pacific, Europe, North America, Latin America, the Middle East, and the Rest of the World. North America emerged as the leading regional market in 2014 with a revenue of US$1.6 bn. The presence of a large pool of biopharmaceutical firms and research institutes played a significant role in driving the market for microbiology culture in North America.
Analysts expect this region to retain its lead over the forecast period. However, Asia Pacific is likely to present the most promising opportunities and register the fastest CAGR of 6.80% from 2015 to 2023. The unmet medical needs of people, coupled with the growing prevalence of infectious diseases, the surge in the healthcare expenditure, the rising focus on food safety, and the increasing demand for antibiotics, are likely to provide an opportunity-rich market for participants in the near future.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3232
Complex Media to Remain Most-preferred Culture Media
Complex media, special media, simple media, and synthetic media are the main culture media utilized in microbial culture. Among these, complex media emerged as the most preferred media for microbiology culture in 2014 and was closely followed by special media. As per estimations, complex media will remain the preferred culture media throughout the forecast period as it caters to a wide range of requirements important for the cultivation of nutritionally complex or kinds of unknown bacteria.
The global market for microbiology culture is led by Sigma-Aldrich Co. LLC, Merck Millipore, Thermo Fisher Scientific Inc., and Becton, Dickinson and Co. In 2014, these four players collectively accounted for a share of more than 50% in the overall market. Some of the other prominent players are BioMérieux SA, Bio-Rad Laboratories, Hi-Media Laboratories Pvt. Ltd., Eiken Chemical Co. Ltd., Scharlab S.L., and Neogen Corp.